Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pricing Transparency Policies Not Suited To Generics, GPhA Argues

Oct 19 2016

• By Cathy Kelly

PharmacyReceipt-Dollars-PillBottles_1200x675

Related Content

The Clinton Drug Price Board, 23 Years Later

Sep 07 2016

For Generics Industry, Will Larger Firms Mean Weaker Lobbying?

Mar 21 2016

EpiPen Price Hearing: House Plays Bootleg Tape Of Shkreli Event

Sep 22 2016

Formalizing 'Name And Shame': New Strategy To Rein In Price Increases

Sep 21 2016

Allergan's Price Reform Pledge: Will Others Follow?

Sep 07 2016

Heated Drug Pricing Debate Fanned By Election, Teva's Olafsson Says

Sep 12 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Merck & Co., Inc.

Viatris Inc.

Vyera Pharmaceuticals, LLC

Bausch Health Companies Inc.

Additional Topics

United States Pricing Debate Elections Market Access Regulation BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window